The nuclear medicine industry is poised for significant growth in the near future, driven by the increasing incidence of cancer and chronic diseases...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - AUMANUFACTURING.COM.AU - A La Une - 19/Aug 22:28
Optiscan eyes the veterinary market for cancer detection
Confocal microscopy manufacturer Optiscan Imaging is looking to expand into the veterinary market with its microscopy imaging system with an initial focus on cancer detection in companion animals. The company has signed MOU with the University of Minnesota College of Veterinary Medicine to enable the development of clinical data for Optiscan’s digital confocal laser endomicroscopic… The post Optiscan eyes the veterinary market for cancer detection appeared first on Australian Manufacturing Forum.
Articles similaires
Northeast Group inks underwriting agreement with Affin Hwang Investment Bank
thestar.com.my - 03/Sep 11:28
PETALING JAYA: Precision engineering components manufacturer Northeast Group Bhd has signed an underwriting agreement with Affin Hwang Investment Bank...
Northeast Group inks underwriting agreement with Affin Hwang Investment Bank
thestar.com.my - 03/Sep 11:28
PETALING JAYA: Precision engineering components manufacturer Northeast Group Bhd has signed an underwriting agreement with Affin Hwang Investment Bank...
10-year study shows DBT outperforms 2D mammography in breast cancer detection
news.medical.net - 16:09
According to a new 10-year study, screening for breast cancer with digital breast tomosynthesis (DBT) increases cancer detection rates and...
Precede Biosciences Presents New Data at ESMO 2024 Demonstrating Ability to Reveal Tumor PSMA Expression from a Simple Blood Test that is Highly Correlated with PSMA-PET Imaging
financialpost.com - 15/Sep 10:08
Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one FDA-approved medicine and 30...
Silfab launches 640 W utility-scale solar panels
pv-magazine-australia.com - 12/Sep 22:57
The Canada-based manufacturer said its new panels have a temperature coefficient of -0.29% per C and an efficiency of up to 22.92%. They come with a...
Veterinary Medicines Directorate: Head of Safety and Efficacy of Biologicals
pharmiweb.com - 03/Sep 16:59
£67,640 - £75,965 per annum : Veterinary Medicines Directorate: The Veterinary Medicines Directorate (VMD) is an Executive Agency of the Department...
Veterinary Medicines Directorate: Head of Quality of Biologicals
pharmiweb.com - 03/Sep 17:13
£67,640- £75,965 per annum : Veterinary Medicines Directorate: The Veterinary Medicines Directorate (VMD) is an Executive Agency of the Department...
Breakthrough in Blood-Based Cancer Gene Detection
medindia.net - 08/Sep 12:37
Cancer mutant genes in blood can be detected by the world's most sensitive technology of 0.000000001% - using plasmonic nanomaterials for optical...
AI model enhances detection of immune-related adverse events in cancer patients
news.medical.net - 04/Sep 03:03
While immune checkpoint inhibitors (ICIs) can provide lifesaving treatment for patients with cancer, they have also been found to cause immune-related...
Les derniers communiqués
-
Aucun élément